Cash Flow Viva Biotech Holdings Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
349.00
320.00
-61.00
-533.00
419.00
-399.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-129.00
-35.00
34.00
-20.00
-315.00
-82.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
229.00
368.00
379.00
351.00
66.00
66.00
Cash Flow from Investing Activities
-104.00
223.00
1,005.00
-420.00
-1,106.00
-4,356.00
Cash Flow from Financing Activities
40.00
-697.00
-950.00
-81.00
-701.00
5,977.00
Net Cash Inflow / Outflow
159.00
-102.00
395.00
-142.00
-1,816.00
1,578.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-6.00
3.00
-39.00
8.00
-76.00
-108.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Viva Biotech Holdings
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
349.757702534676
-157.746093318347
506.00
321.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-129.672121343821
-79.8556248330484
-50.00
-62.38%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
229.394045281767
-207.302304220147
436.00
210.66%
Cash Flow from Investing Activities
-104.390797048906
-154.347197074503
50.00
32.37%
Cash Flow from Financing Activities
40.7553037483856
50.3283915417542
-10.00
-19.02%
Net Cash Inflow / Outflow
159.485668804986
-328.953290714104
487.00
148.48%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-6.27288317625967
-17.6321809612084
11.00
64.42%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -37.75% vs -2.90% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
229.39
368.49
-37.75%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
